Back to Search
PARMATMA PARAJULI, MD
MD
Hospitalist Physician
NPI: 1780108589IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
ME145047(FL)
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
TRN25708(FL)
Hospitalist PhysicianPrimary
Hospitalist
Code: 208M00000X
ME145047(FL)
CMS Specialties
PrimaryINTERNAL MEDICINE
Education
OTHER
Class of 2006
Research & Publications (17)
In vitro antitumor mechanisms of various Scutellaria extracts and constituent flavonoids.
PMID 19031366·Planta Med·2009
8-other
Source specific fecal bacteria modeling using soil and water assessment tool model.
PMID 18703332·Bioresour Technol·2009
8-other
Dendritic cell-based active specific immunotherapy for malignant glioma.
PMID 17373896·Expert Opin Biol Ther·2007
6-review
Lactate and malignant tumors: a therapeutic target at the end stage of glycolysis.
PMID 17354062·J Bioenerg Biomembr·2007
6-review
Antidiabetic plants used by Sikkim and Darjeeling Himalayan tribes, India.
PMID 15894127·J Ethnopharmacol·2005
8-other
Silencing of monocarboxylate transporters via small interfering ribonucleic acid inhibits glycolysis and induces cell death in malignant glioma: an in vitro study.
PMID 15574223·Neurosurgery·2004
8-other
Systematic comparison of dendritic cell-based immunotherapeutic strategies for malignant gliomas: in vitro induction of cytolytic and natural killer-like T cells.
PMID 15509326·Neurosurgery·2004
4-observational
Regional, but not systemic recruitment/expansion of dendritic cells by a pluronic-formulated Flt3-ligand plasmid with vaccine adjuvant activity.
PMID 12798646·Vaccine·2003
7-preclinical
Flt3 ligand augmentation of T cell mitogenesis and expansion of type 1 effector/memory T cells.
PMID 12188034·Int Immunopharmacol·2002
7-preclinical
Flt3 ligand and conjugation to IL-1beta peptide as adjuvants for a type 1, T-cell response to an HIV p17 gag vaccine.
PMID 12009292·Vaccine·2002
7-preclinical
Humanized anti-ganglioside GM2 antibody is effective to induce antibody-dependent cell-mediated cytotoxicity in mononuclear cells from lung cancer patients.
PMID 11275367·Cancer Lett·2001
7-preclinical
Immunization with wild-type p53 gene sequences coadministered with Flt3 ligand induces an antigen-specific type 1 T-cell response.
PMID 11719454·Cancer Res·2001
7-preclinical
Flt3 ligand and granulocyte-macrophage colony-stimulating factor preferentially expand and stimulate different dendritic and T-cell subsets.
PMID 11602320·Exp Hematol·2001
7-preclinical
Flt3 ligand enhances the immunogenicity of a gag-based HIV-1 vaccine.
PMID 11090695·Int J Immunopharmacol·2000
7-preclinical
Human interferon-gamma enhances expression of ganglioside GM2 on human lung cancer cells and their susceptibility for antiganglioside GM2 monoclonal antibody-dependent cellular cytotoxicity.
PMID 11341466·Oncol Res·2000
8-other
Comparison of the hematopoietic activity of flt-3 ligand and granulocyte-macrophage colony-stimulating factor acting alone or in combination.
PMID 11091495·J Hematother Stem Cell Res·2000
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 515 WEKIVA COMMONS CIR
APOPKA, FL 32712 - Phone
- (407) 464-9516
Quick Facts
- NPI
- 1780108589
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 2
- Years in Practice
- 20
- Publications
- 17
Are you this provider?
Claim Your Profile